Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

1. my.elanco.com › us › parvoCanine Parvovirus Monoclonal Antibody - Elanco

   my.elanco.com › us › parvo

   • Αποθηκευμένο αντίγραφο

   Canine Parvovirus Monoclonal Antibody is the first and only USDA-conditionally approved monoclonal antibody (mAb) treatment that targets canine parvovirus (CPV).

2. www.elanco.com › en-us › insightsElanco Announces Breakthrough Treatment for Deadly Canine...

   www.elanco.com › en-us › insights

   • Αποθηκευμένο αντίγραφο

   2 Μαΐ 2023 · With an estimated 330,000 cases of canine parvovirus available for treatment in the U.S. annually 2, clinical trials demonstrate that the Canine Parvovirus Monoclonal Antibody single, intravenous dose delivers targeted efficacy in treating this deadly disease.

3. yourpetandyou.elanco.com › us › our-productsCanine Parvovirus Monoclonal Antibody - Elanco

   yourpetandyou.elanco.com › us › our-products

   • Αποθηκευμένο αντίγραφο

   Canine Parvovirus Monoclonal Antibody (CPMA) is the first and only USDA-conditionally approved, one-dose parvovirus treatment.

4. www.elanco.com › en-us › newsNew Data Reveals Elanco’s Canine Parvovirus Monoclonal Antibody...

   www.elanco.com › en-us › news

   • Αποθηκευμένο αντίγραφο

   15 Οκτ 2024 · Elanco Animal Health today unleashed the first ever real-world data demonstrating the efficacy and impact of its Canine Parvovirus Monoclonal Antibody (CPMA), the first and only USDA Conditionally Approved targeted treatment for canine parvovirus.

5. my.elanco.com › us › campaignFight Canine Parvovirus - Elanco

   my.elanco.com › us › campaign

   • Αποθηκευμένο αντίγραφο

   Canine Parvovirus Monoclonal Antibody is the first and only USDA-conditionally approved monoclonal antibody (mAb) treatment that targets canine parvovirus (CPV).

6. investor.elanco.com › press-releases › press-releases-detailsElanco Announces Breakthrough Treatment for Deadly Canine...

   investor.elanco.com › press-releases › press-releases-details

   • Αποθηκευμένο αντίγραφο

   2 Μαΐ 2023 · The Canine Parvovirus Monoclonal Antibody treatment may provide a less intensive and more effective solution than supportive care alone by targeting the virus with single dose efficacy and a strong safety profile in healthy dogs.

7. assets.elanco.com › 0cec44ed-3eaa-0009/2029/666567e7e4de › 87dab147-6af7-4c4a-83cfTREAT PARVO FIGHT PARVO - Elanco

   assets.elanco.com › 0cec44ed-3eaa-0009/2029/666567e7e4de › 87dab147-6af7-4c4a-83cf

   Canine Parvovirus Monoclonal Antibody is the first and only USDA-conditionally approved monoclonal antibody (mAb) treatment that targets CPV. Now you can take charge of parvo with a targeted treatment that helps ease the stress of your patients, your clients and your clinic. Targets parvovirus directly Single-dose efficacy High safety profile